Ensysce Biosciences, Inc.
ENSC
$0.47
$0.000.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.57M | -3.56M | -2.77M | -3.73M | -1.73M |
| Total Depreciation and Amortization | 6.50K | 6.50K | 6.50K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 648.30K | 11.80K | 442.10K | 98.70K | 251.40K |
| Change in Net Operating Assets | -46.60K | 37.10K | 793.20K | 1.76M | -1.22M |
| Cash from Operations | -1.96M | -3.50M | -1.53M | -1.87M | -2.71M |
| Capital Expenditure | -- | -- | 0.00 | -123.60K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -123.60K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -63.90K | -105.00K | -40.00K | -24.10K |
| Issuance of Common Stock | -- | -- | 684.40K | 1.50M | 42.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.00M | -- | 3.98M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -106.30K | -- | -391.40K | -5.40K | 1.85M |
| Cash from Financing | 1.89M | -63.90K | 4.16M | 1.45M | 1.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.80K | -3.56M | 2.64M | -538.40K | -840.90K |